Phase I study of vaccine therapy with a cocktail of peptides for pediatric patients with refractory solid tumors

被引：1
|
作者：
Akazawa, Yu
Hosono, Ako
Yoshikawa, Toshiaki
Kaneda, Hide
Hara, Junichi
Kinoshita, Yoshiaki
Kohashi, Kenichi
Manabe, Atsushi
Shioda, Yoko
Shoda, Kayoko
Shimomura, Manami
Mizuno, Shoichi
Nakamoto, Yasunari
Nakatsura, Tetsuya
机构：
[1] Natl Canc Ctr, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Osaka City Gen Hosp, Osaka, Japan
[4] Kyushu Univ Hosp, Fukuoka, Japan
[5] St Lukes Int Hosp, Tokyo, Japan
[6] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[7] Univ Fukui, Fukui, Japan
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A001
引用
收藏
页数：2
相关论文
共 50 条
  • [41] First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors
    Takagi, Masatoshi
    Ogawa, Chitose
    Iehara, Tomoko
    Aoki-Nogami, Yuki
    Ishibashi, Eri
    Imai, Minoru
    Kimura, Toshimi
    Nagata, Masashi
    Yasuhara, Masato
    Masutani, Mitsuko
    Yoshimura, Kenichi
    Tomizawa, Daisuke
    Ogawa, Atsushi
    Yonemori, Kan
    Morishita, Aoi
    Miyamoto, Satoshi
    Takita, Junko
    Kihara, Tetsuro
    Nobori, Kiyoshi
    Hasebe, Kazuhisa
    Miya, Fuyuki
    Ikeda, Sadakatsu
    Shioda, Yoko
    Matsumoto, Kimikazu
    Fujimura, Junya
    Mizutani, Shuki
    Morio, Tomohiro
    Hosoi, Hajime
    Koike, Ryuji
    CANCER, 2022, 128 (15) : 2949 - 2957
  • [42] Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors
    Meany, Holly J.
    Widemann, Brigitte C.
    Hinds, Pamela S.
    Bagatell, Rochelle
    Shusterman, Suzanne
    Stern, Emily
    Jayaprakash, Nalini
    Peer, Cody J.
    Figg, William D.
    Hall, O. Morgan
    Sissung, Tristan M.
    Kim, Aerang
    Fox, Elizabeth
    London, Wendy B.
    Rodriguez-Galindo, Carlos
    Minturn, Jane E.
    Dome, Jeffrey S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (11)
  • [43] Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: A children's oncology group study
    Bender, Julia L. Glade
    Adamson, Peter C.
    Reid, Joel M.
    Xu, Lu
    Baruchel, Sylvain
    Shaked, Yuval
    Kerbel, Robert S.
    Cooney-Qualter, Erin M.
    Stempak, Diana
    Chen, Helen X.
    Nelson, Marvin D.
    Krailo, Mark D.
    Ingle, Ashish M.
    Blaney, Susan M.
    Kandel, Jessica J.
    Yamashiro, Darrell J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 399 - 405
  • [44] A PHASE-I TRIAL OF FAZARABINE IN REFRACTORY PEDIATRIC SOLID TUMORS - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    BERNSTEIN, ML
    WHITEHEAD, VM
    GRIER, H
    DUBOWY, R
    LAND, V
    DEVINE, S
    MURPHY, S
    KUNG, F
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) : 309 - 312
  • [45] A phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
    Cash, Thomas
    Jonus, Hunter C.
    Tsvetkova, Maya
    Beumer, Jan Hendrik
    Lee, Jasmine Y.
    Henry, Curtis
    Aguilera, Dolly
    Harvey, R. Donald
    Goldsmith, Kelly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors
    McGregor, Lisa M.
    Stewart, Clinton F.
    Crews, Kristine R.
    Tagen, Michael
    Wozniak, Amy
    Wu, Jianrong
    McCarville, M. Beth
    Navid, Fariba
    Santana, Victor M.
    Houghton, Peter J.
    Furman, Wayne L.
    Galindo, Carlos Rodriguez
    PEDIATRIC BLOOD & CANCER, 2012, 58 (03) : 372 - 379
  • [47] Cefixime allows greater dose escalation of oral irinotecan: A phase I study in pediatric patients with refractory solid tumors
    Furman, WL
    Crews, KR
    Billups, C
    Wu, JR
    Gajjar, AJ
    Daw, NC
    Patrick, CC
    Rodriguez-Galindo, C
    Stewart, CF
    Dome, JS
    Panetta, JC
    Houghton, PJ
    Santana, VM
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 563 - 570
  • [48] A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
    Mascarenhas, Leo
    Malogolowkin, Marcio
    Armenian, Saro H.
    Sposto, Richard
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2013, 60 (07) : 1103 - 1107
  • [49] Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors
    Merchant, Melinda S.
    Geller, James I.
    Baird, Kristin
    Chou, Alexander J.
    Galli, Susana
    Charles, Ava
    Amaoko, Martha
    Rhee, Eunice H.
    Price, Anita
    Wexler, Leonard H.
    Meyers, Paul A.
    Widemann, Brigitte C.
    Tsokos, Maria
    Mackall, Crystal L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (33) : 4141 - 4147
  • [50] Phase I study of docetaxel and temsirolimus in refractory solid tumors
    Mwandoro, T. N.
    Gao, F.
    Lockhart, A. C.
    Suresh, R.
    Tan, B. R.
    Wang-Gillam, A.
    Fracasso, P. M.
    Picus, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345